Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,219,057
+$3,568,685 QoQ
Shares Held
106,949
+8.3% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 211 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. ANAB ranks #83 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in ANAB
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,219,057 | 106,949 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,650,372 | 65,820 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $1,449,302 | 47,332 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,870,077 | 354,508 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,588,110 | 354,391 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,691,876 | 354,370 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,871,377 | 354,370 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $11,662,270 | 465,373 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,480,176 | 465,373 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,677,563 | 405,115 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $5,928,399 | 330,090 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $260,763 | 10,222 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $203,912 | 10,045 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $366,942 | 14,832 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $515,134 | 14,824 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $404,088 | 14,900 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||